Healthcare -
Biotechnology - NASDAQ - US
$ 25.18
-1.33 %
$ 3.16 B
Market Cap
-15.74
P/E
APLS - TOTAL CURRENT LIABILITIES
Total Current Liabilities APLS - Apellis Pharmaceuticals, Inc.
186 M
LAST VALUE
5.20%
2 YEAR CAGR
23.05%
5 YEAR CAGR
67.28%
10 YEAR CAGR